Resources
Menu
Close
Resources
Contact us
Oral solid dose
Sterile injectables
Antibody-drug conjugates
Tech transfer
OSD manufacturing
SI manufacturing
ADC manufacturing
Careers
Leadership team
Regulatory support
Sustainability
IP protection
Expert insights
Considerations for Migrating a Drug Product Presentation from Vial to Pre-Filled Syringe
An increasing number of pharmaceutical companies are searching for Contract Development and Manufacturing Organizations (CDMOs) that can support them in converting an existing product presentation into a different final container type.
Most often, the tech transfer required is in converting drug products from a vial into a prefilled syringe (PFS). From the patient centricity benefits to product safety enhancements, the demand for PFS treatments has skyrocketed, and CDMOs must keep up.
This whitepaper outlines the benefits of PFS transfer, the differences between glass and PFS devices, and the key engineering processes required to successfully carry out this process.
Please submit the form below to download your resource
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please click below.
By clicking here and clicking “Submit” below, I consent to receiving thought leadership, industry news, and invitations by email or other electronic means, which Pfizer CentreOne believes may be of value to me, relevant to my work and tailored to my professional profile and interests. This may include promotional information on products, services and events provided or organized by Pfizer CentreOne.
By clicking the "Submit” button, you confirm that the information you have provided above is correct, and you agree to Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy Policy and Pfizer website terms of use.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Submit
Success
Thank you, your submission has been received!
Success
Thank you, your submission has been received!
Latest marketing updates
Let’s stay in touch
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
BY TICKING THE BOX AND CLICKING “LET’S COLLABORATE” BELOW, I CONSENT TO RECEIVING THOUGHT LEADERSHIP, INDUSTRY NEWS, AND INVITATIONS BY EMAIL OR OTHER ELECTRONIC MEANS, WHICH PFIZER CENTREONE BELIEVES MAY BE OF VALUE TO ME, RELEVANT TO MY WORK AND TAILORED TO MY PROFESSIONAL PROFILE AND INTERESTS. THIS MAY INCLUDE PROMOTIONAL INFORMATION ON PRODUCTS, SERVICES AND EVENTS PROVIDED OR ORGANIZED BY PFIZER CENTREONE.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Let's Collaborate
A CMO for therapies that define legacies
Follow us
Latest marketing updates
Sign up
© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use